Maple Leafs’ 2020 first-round pick Amirov diagnosed with serious medical condition

This is terrible news for the young forward Rodion Amirov, who is just 20 years.

On Wednesday morning, Toronto Maple Leafs general manager Kyle Dubas provided an update on the status of Amirov, who was selected in the first round (15th overall) from the 2020 NHL Draft. The young prospect has been diagnosed with a brain tumour. Here is the full statement from Dubas:

“I regret to inform our fans that Rodion Amirov has been diagnosed with a brain tumour.

Rodion commenced the 2021-22 season with Salavat Ufa of the KHL but suffered an injury to open the season. During the course of his recovery from this injury, he developed some new, unrelated symptoms that required ongoing extensive investigations over the last few months.

Rodion is currently undergoing treatment at a medical facility in Germany and will not return to play for the remainder of the season.

Our medical staff has been involved throughout the process alongside Ufa’s and we are in direct contact with the facility on an ongoing basis to monitor his treatment and care. Rodion has the complete support of the Toronto Maple Leafs organization and we will continue to ensure he receives the best care possible throughout this process.

Out of respect for Rodion and his family, the Club will not have any further comment at this time.”

Rodion Amirov's agent, Dan Milstein, has stated that Amirov continues to skate three times per week while receiving treatment for his brain tumour in Germany.

We too offer him support here at Hockey Feed. Life is more than hockey. Best wishes for a healthy recovery.